Puerto Rico Pharmaceuticals & Healthcare Q4 2018
Puerto Rico’s pharmaceutical and healthcare expenditure will grow at a modest rate over the next five years.The healthcare budget will restrict growth as cost measures targeting drug spending rise and the US administration maintainsa stringent stance towards securing federal healthcare funds for Puerto Rico. Economic challenges and outward migration of labourwill further raise risks to the island's attractiveness to manufacturers, including pharmaceutical producers. However, over our ten-year forecast period, internal devaluation is likely to drive labour and operational costs down, strengthening theisland's competitiveness and therefore its longstanding attractiveness as a manufacturing base.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook